News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Appropriate Use of Stimulant Medications in Adults With ADHD: A Psychiatric Times Custom Video Series

EP. 1: Chapter 1. History of Stimulants in ADHD

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 2: Chapter 2. Guidance and Recommendations for the use of Stimulants in Adults With ADHD

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 3: Chapter 3. Pharmacokinetic Profiles of Long-Acting Stimulants

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 4: Chapter 4. Optimal Treatment Outcomes for Treating Patients With ADHD

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 5: Chapter 5. Adult Perspectives on ADHD Medications

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 6: Chapter 6. Optimizing the Duration of Effect with Stimulant Medications

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 7: Chapter 7. Stimulant Prescribing Practices for Patients With ADHD

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 8: Chapter 8. Managing Patient Expectations During Treatment for ADHD

By

August 31st 2023

Sponsored by: Ironshore Pharmaceuticals

EP. 9: Appropriate Use of Stimulant Medications in Adults With ADHD

October 19th 2023

Trending on Psychiatric Times

Correctional Psychiatry Enters a New Era: NCCHC Releases 2026 Mental Health Standards

The Deadly Days and What Makes Life Worth Living Better

Presenting Our November Theme: Best Practices

© 2025 MJH Life Sciences^®

All rights reserved.